Lung Cancer
Volume 66, Issue 3 , Pages 305-308 , December 2009

Sarcoidal reactions in regional lymph nodes of patients with non-small cell lung cancer: Incidence and implications for minimally invasive staging with endobronchial ultrasound

Received 22 January 2009 ,Revised 17 February 2009 ,Accepted 1 March 2009.

References 

  1. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:243S–265S
  2. Yasufuku K, Nakajima T, Motoori K, Sekine Y, Shibuya K, Hiroshima K, et al. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest. 2006;130:710–718
  3. Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol. 2008;3:577–582
  4. Garwood S, Judson MA, Silvestri G, Hoda R, Fraig M, Doelken P. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest. 2007;132:1298–1304
  5. Oki M, Saka H, Kitagawa C, Tanaka S, Shimokata T, Kawata Y, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration is useful for diagnosing sarcoidosis. Respirology. 2007;12:863–868
  6. Wong M, Yasufuku K, Nakajima T, Herth FJ, Sekine Y, Shibuya K, et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J. 2007;29:1182–1186
  7. Shigemitsu H. Is sarcoidosis frequent in patients with cancer?. Curr Opin Pulm Med. 2008;14:478–480
  8. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710–1717
  9. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–1723
  10. Tomimaru Y, Higashiyama M, Okami J, Oda K, Takami K, Kodama K, et al. Surgical results of lung cancer with sarcoid reaction in regional lymph nodes. Jpn J Clin Oncol. 2007;37:90–95
  11. Kamiyoshihara M, Hirai T, Kawashima O, Ishikawa S, Morishita Y. Sarcoid reactions in primary pulmonary carcinoma: report of seven cases. Oncol Rep. 1998;5:177–180
  12. Sharma OP. Sarcoidosis around the world. Clin Chest Med. 2008;29:357–363vii
  13. Laurberg P. Sarcoid reactions in pulmonary neoplasms. Scand J Respir Dis. 1975;56:20–27
  14. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736–55.
  15. Reich JM. What is sarcoidosis?. Chest. 2003;124:367–371
  16. Kreider ME, Christie JD, Thompson B, Newman L, Rose C, Barnard J, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest. 2005;128:207–215
  17. Reich JM, Mullooly JP, Johnson RE. Linkage analysis of malignancy-associated sarcoidosis. Chest. 1995;107:605–613
  18. Shigemitsu H, Yarbrough CA, Prakash S, Sharma OP. A 65-year-old woman with subcutaneous nodule and hilar adenopathy. Chest. 2008;134:1080–1083
  19. Brincker H, Pedersen NT. Immunohistologic separation of B-cell-positive granulomas from B-cell-negative granulomas in paraffin-embedded tissues with special reference to tumor-related sarcoid reactions. Apmis. 1991;99:282–290
  20. Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol. 2007;25:326–333
  21. Spier CM, Lippman SM, Miller TP, Grogan TM. Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival.. Cancer. 1988;61:517–524
  22. Kennedy MP, Jimenez CA, Mhatre AD, Morice RC, Eapen GA. Clinical implications of granulomatous inflammation detected by endobronchial ultrasound transbronchial needle aspiration in patients with suspected cancer recurrence in the mediastinum. J Cardiothorac Surg. 2008;3:8
  23. Suen JS, Forse MS, Hyland RH, Chan CK. The malignancy–sarcoidosis syndrome. Chest. 1990;98:1300–1302
  24. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med. 1999;160:1668–1672
  25. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer. 1974;29:247–251
  26. Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J. 1998;12:906–912
  27. Seersholm N, Vestbo J, Viskum K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax. 1997;52:892–894
  28. Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med. 2007;101:2534–2540
  29. Gillman A, Steinfort C. Sarcoidosis in Australia. Intern Med J. 2007;37:356–359
  30. Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev. 1986;13:147–156
  31. Yamasawa H, Ishii Y, Kitamura S. Concurrence of sarcoidosis and lung cancer. A report of four cases. Respiration. 2000;67:90–93
  32. Marchevsky AM, Qiao JH, Krajisnik S, Mirocha JM, McKenna RJ. The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 2003;126:551–557
  33. Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T. Preoperative prognostic factors for pN2 non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2006;12:15–20
  34. Watanabe A, Mishina T, Ohori S, Koyanagi T, Nakashima S, Mawatari T, et al. Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?. Eur J Cardiothorac Surg. 2008;33:812–818
  35. Rena O, Carsana L, Cristina S, Papalia E, Massera F, Errico L, et al. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. Eur J Cardiothorac Surg. 2007;32:863–867
  36. Niizeki H, Morikawa T, Okushiba S, Kondo S, Katoh H. Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2004;10:9–13
  37. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, et al. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132:178S–201S
  38. Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007;132:1949–1953
  39. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:202S–220S
  40. Shinkal H, Kitayama J, Kimura W, Muto T, Shibata Y. Functional expression of CD11a on CD8+ cells is suppressed in regional lymph nodes with cancer involvement in patients with gastrointestinal carcinoma. Cancer. 1996;78:1677–1685
  41. Laguens G, Coronato S, Laguens R, Portiansky E, Di Girolamo V. Human regional lymph nodes draining cancer exhibit a profound dendritic cell depletion as comparing to those from patients without malignancies. Immunol Lett. 2002;84:159–162

PII: S0169-5002(09)00125-1

doi: 10.1016/j.lungcan.2009.03.001

Lung Cancer
Volume 66, Issue 3 , Pages 305-308 , December 2009

Article Tools

* Image Usage & Resolution